Skip to main content
Colorful abstract image with organic shape
ktsdesign - stock.adobe.com

Pathophysiology of Prediabetes

About our research

Our goal is to understand the causes and consequences of impaired metabolic health in obesity and normal weight and the role of metabolic dysfunction-associated steatotic liver disease (MASLD) in the pathogenesis of prediabetes, type 2 diabetes and cardiovascular diseases.

In this respect, in 2008, we published the first large cohort study addressing precise phenotyping in metabolically healthy obesity (MHO) and then extended our research to subphenotypes of impaired metabolic in normal weight. To address the mechanisms how MASLD impacts on cardiometabolic diseases, in 2008, we were the first to introduce the concept of hepatokines and are studying their cardiometabolic role in the organ cross-talk.

Scientists at Pathophysiology of Prediabetes

Tobias_Haueise_MedKlinik_Portraits213_ 176

Tobias Haueise

PhD student
Costas_Kartazis

Dr. Konstantinos Kantartzis

Physician Scientist
Portraitfoto Angela_Lehn_Stefan

Dr. Angela Lehn-Stefan

Physician Scientist

Dr. Sebastian Schuth

Physician Scientist

Karin Waneck

TA

Highlight Publications

Contact

Prof_Stefan_ Porträt 1(1)

Prof. Dr. Norbert Stefan

Head of Section